TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34419870

Group type: EXPERIMENTAL
Intervention: Footbath with water at 40°C
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Footbath with water at 37°C
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 35271601

Group type: EXPERIMENTAL
Intervention: Healthy Start intervention
Number of subjects: 543

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 543
Study: 32790020

Group type: EXPERIMENTAL
Intervention: Supervised exercise
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Home-based exercise
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 148

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 148
Study: 32102667

Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 99

Group type: COMPARATOR
Intervention: MICT
Number of subjects: 99
Study: 36279375

Group type: EXPERIMENTAL
Intervention: Hardware-software complex with biofeedback (BFB) as part of a comprehensive rehabilitation program for 21 days.
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard rehabilitation program without biofeedback procedures.
Number of subjects: 79
Study: 34172548

Group type: EXPERIMENTAL
Intervention: Fully immunised children
Number of subjects: 1254

Group type: COMPARATOR
Intervention: Children in rural communities
Number of subjects: 1254

Group type: COMPARATOR
Intervention: Children in urban communities
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Children of single mothers
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Children delivered without skilled birth attendant
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Children of mothers who did not receive postnatal care
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Children of mothers with poor knowledge of routine immunisation
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Children dwelling in rural districts
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Children from low-income families
Number of subjects: 1254

Group type: EXPERIMENTAL
Intervention: Children living further than 30 min from the nearest vaccination facility
Number of subjects: 1254
Study: 34529864

Group type: EXPERIMENTAL
Intervention: Video alone
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Booklet alone
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Booklet and video together
Number of subjects: 522

Group type: COMPARATOR
Intervention: Without intervention
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Booklet alone (countryside)
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Video alone (countryside)
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Booklet and video together (countryside)
Number of subjects: 522

Group type: COMPARATOR
Intervention: Without intervention (countryside)
Number of subjects: 522
Study: 34416084

Group type: EXPERIMENTAL
Intervention: Low-dose whole-lung irradiation (WLI) 1 Gy
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 11
Study: 35881012

Group type: EXPERIMENTAL
Intervention: Systematic voiding programme
Number of subjects: 157

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 157
Study: 33186894

Group type: EXPERIMENTAL
Intervention: AEL65 (3 × 5 at 120%/65% 1-RM)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: AEL80 (3 × 3 at 120%/80% 1-RM)
Number of subjects: 21
Study: 35985037

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (50,000 IU/w for 12 weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 32417976

Group type: EXPERIMENTAL
Intervention: Remimazolam 6 mg/kg/h
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Remimazolam 12 mg/kg/h
Number of subjects: 375

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 375
Study: 34264503

Group type: EXPERIMENTAL
Intervention: FKB238 15 mg/kg
Number of subjects: 731

Group type: COMPARATOR
Intervention: Bevacizumab 15 mg/kg
Number of subjects: 731
Study: 35001547

Group type: EXPERIMENTAL
Intervention: Best-possible-self intervention
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Gratitude letter
Number of subjects: 432

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Self-compassion condition
Number of subjects: 432
Study: 32579856

Group type: EXPERIMENTAL
Intervention: Sequential analysis of swallows by two trained raters measuring all kinematic events within each swallow.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Random analysis of swallows by two trained raters measuring one kinematic event at a time.
Number of subjects: 18
Study: 35654771

Group type: EXPERIMENTAL
Intervention: Exercise + nutrient-dense weight maintenance
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Exercise + nutrient-dense caloric restriction of 500 kcal/d
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group (exercise only)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Exercise + intentional weight loss
Number of subjects: 163
Study: 32992190

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) beyond 90 days (on clopidogrel)
Number of subjects: 397

Group type: COMPARATOR
Intervention: Aspirin alone (off clopidogrel)
Number of subjects: 397
Study: 36036673

Group type: EXPERIMENTAL
Intervention: Nursing care based on Watson's Theory of Human Caring
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study: 34230959

Group type: EXPERIMENTAL
Intervention: IS-MiHealth digital tool for screening
Number of subjects: 14598

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 14598
Study: 33498678

Group type: EXPERIMENTAL
Intervention: Dietary monitoring app with a three-hour nutrition seminar
Number of subjects: 305

Group type: COMPARATOR
Intervention: Control group receiving a three-hour nutrition seminar
Number of subjects: 305
Study: 32179001

Group type: EXPERIMENTAL
Intervention: Intervention arm (clinical pharmacist applying a validated 5-step tool)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Comparison arm (routine care)
Number of subjects: 242
Study: 36040780

Group type: EXPERIMENTAL
Intervention: Digital intervention for depression
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Combined model of baseline characteristics and intervention usage data
Number of subjects: 253
Study: 32568732

Group type: EXPERIMENTAL
Intervention: Zingiber officinale (ZO) 500 mg b.i.d. + Curcuma longa L. (CL) 500 mg b.i.d. (ZO + CL)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Zingiber officinale (ZO) 500 mg b.i.d. + placebo CL (b.i.d.) (ZO + P)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Placebo ZO (b.i.d.) + Curcuma longa L. (CL) 500 mg b.i.d. (CL + P)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo ZO (b.i.d.) + placebo CL (b.i.d.) (P + P)
Number of subjects: 120
Study: 35303909

Group type: EXPERIMENTAL
Intervention: bamlanivimab (700 mg, 2800 mg, or 7000 mg)
Number of subjects: 23

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 23
Study: 34000126

Group type: EXPERIMENTAL
Intervention: Folinic acid (leucovorin) supplementation
Number of subjects: 115

Group type: COMPARATOR
Intervention: No leucovorin supplementation (control)
Number of subjects: 115
Study: 35751108

Group type: EXPERIMENTAL
Intervention: Upadacitinib (UPA) 15 mg/day
Number of subjects: 612

Group type: COMPARATOR
Intervention: Abatacept (ABA)
Number of subjects: 612
Study: 33788419

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (10,000 IU/day for 2 weeks, followed by 2000 IU/day for 28 weeks)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Resistance training (twice weekly for 13 weeks)
Number of subjects: 95
Study: 32541480

Group type: EXPERIMENTAL
Intervention: Systematic training program based on the concept of combination of medicine and care for 4 months
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine training following 'National Occupational Standards of Elderly Nursing Staff'
Number of subjects: 34
Study: 34030178

Group type: EXPERIMENTAL
Intervention: Multicomponent familiarization intervention (visual activity schedule and video-enhanced system of least-to-most prompting via iPad)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Active control group (CG)
Number of subjects: 24
Study: 36190185

Group type: EXPERIMENTAL
Intervention: Endoscopic submucosal dissection with insulated-tip knife (ESD-IT)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Endoscopic submucosal dissection with needle-type knife (ESD-N)
Number of subjects: 223
Study: 32162239

Group type: EXPERIMENTAL
Intervention: Licorice flavonoid oil (LFO) supplementation (300 mg daily for 16 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo (daily for 16 weeks)
Number of subjects: 73
Study: 32251265

Group type: EXPERIMENTAL
Intervention: GFAP + prehospital characteristics (PH)
Number of subjects: 243

Group type: COMPARATOR
Intervention: PH alone
Number of subjects: 243
Study: 33764845

Group type: EXPERIMENTAL
Intervention: Family Connections intervention (10 group sessions over 6 months)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Family Connections intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison group (usual care)
Number of subjects: 100
Study: 33851448

Group type: EXPERIMENTAL
Intervention: 80 mg/day nano-curcumin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 36081341

Group type: EXPERIMENTAL
Intervention: Ways of Being (WoB)
Number of subjects: 463

Group type: COMPARATOR
Intervention: Typical museum website (Ashmolean)
Number of subjects: 463
Study: 34357516

Group type: EXPERIMENTAL
Intervention: TETA 4HCl (trientine tetrahydrochloride)
Number of subjects: 23

Group type: COMPARATOR
Intervention: TETA 2HCl (trientine dihydrochloride)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: TETA 4HCl
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 23
Study: 32909787

Group type: EXPERIMENTAL
Intervention: Two-qubit logic gate using a single laser of wavelength 402 nm.
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Full randomized benchmarking, gate set tomography, and Bell state analysis.
Number of subjects: 2
Study: 36333892

Group type: EXPERIMENTAL
Intervention: Immediate skin-to-skin contact
Number of subjects: 91

Group type: COMPARATOR
Intervention: Conventional care in an incubator
Number of subjects: 91
Study: 33217700

Group type: EXPERIMENTAL
Intervention: Youth Early-intervention Study (YES) intervention
Number of subjects: 133
Study: 32267102

Group type: EXPERIMENTAL
Intervention: STN‐DBS
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: STN + SNr‐DBS
Number of subjects: 15

Group type: COMPARATOR
Intervention: STIM OFF
Number of subjects: 15

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 15
Study: 34233989

Group type: EXPERIMENTAL
Intervention: Common elements-based intervention (15 individual sessions on a monthly basis)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Treatment-as-usual (control group)
Number of subjects: 250
Study: 32584889

Group type: EXPERIMENTAL
Intervention: Any violence victimization
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Past-year violence victimization
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Polyvictimization
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Psychological abuse
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Physical violence
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Forced sex
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Violence from friends/peers
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Violence from romantic partners
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Violence from parents/caregivers
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Violence from strangers
Number of subjects: 272
Study: 32492712

Group type: EXPERIMENTAL
Intervention: Standard-dose prophylactic anticoagulation
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: D-dimer >2,500 ng/mL
Number of subjects: 400
Study: 34059401

Group type: EXPERIMENTAL
Intervention: Lithium carbonate 150–600 mg daily
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 34787248

Group type: EXPERIMENTAL
Intervention: 35%‐hydrogen peroxide (HP)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Violet light (VL)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ozone (OZ)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Violet light with hydrogen peroxide (VL+HP)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ozone with hydrogen peroxide (OZ+HP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Violet light (VL) and Ozone (OZ) used alone
Number of subjects: 15
Study: 33555982

Group type: EXPERIMENTAL
Intervention: Hybrid closed loop (HCL) system (Medtronic 670G™)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard insulin pump therapy
Number of subjects: 17
Study: 36049047

Group type: EXPERIMENTAL
Intervention: nCaF2‐primer
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control primer (Transbond)
Number of subjects: 31
Study: 34438354

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 2000 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 32568198

Group type: EXPERIMENTAL
Intervention: Cognitive remediation (CR) plus transcranial direct current stimulation (tDCS)
Number of subjects: 375

Group type: COMPARATOR
Intervention: Sham cognitive remediation (sham-CR) plus sham transcranial direct current stimulation (sham-tDCS)
Number of subjects: 375
Study: 36173561

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 57
Study: 34212474

Group type: EXPERIMENTAL
Intervention: SNT+RUTF
Number of subjects: 260

Group type: COMPARATOR
Intervention: SNT
Number of subjects: 260
Study: 32595523

Group type: EXPERIMENTAL
Intervention: Oral Contraceptive (OC)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Natural Menstrual Cycles (MC)
Number of subjects: 47
Study: 36476332

Group type: EXPERIMENTAL
Intervention: Umbilical group
Number of subjects: 144

Group type: COMPARATOR
Intervention: Nipple group
Number of subjects: 144

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 144
Study: 33303455

Group type: EXPERIMENTAL
Intervention: Severe Maternal Morbidity (SMM)
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Children from SMM group
Number of subjects: 638

Group type: COMPARATOR
Intervention: Control group (without SMM)
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: SMM group
Number of subjects: 638
Study: 36473477

Group type: EXPERIMENTAL
Intervention: Video group (received video of PCNL procedure)
Number of subjects: 109

Group type: COMPARATOR
Intervention: No-video group (received only written and verbal information)
Number of subjects: 109
Study: 33559438

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment at 5-6 local acupoints and 3-4 distal acupoints, retained for 30 min, three times a week for 8 weeks.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sham acupuncture treatment with shallow needling technique at non-acupoint, retained for 30 min, three times a week for 8 weeks.
Number of subjects: 42
Study: 32459651

Group type: EXPERIMENTAL
Intervention: Web-based diabetes prevention program (DPP) with step-dependent feedback messages and SMS texts over 12 months.
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard web-based DPP without SMS texts (control group).
Number of subjects: 200
Study: 35998021

Group type: EXPERIMENTAL
Intervention: GoalKeeper (GK), an internet-based system for eliciting and monitoring family-centered goals for CMC, used during an initial clinic visit and for 3 months after.
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: GoalKeeper (GK)
Number of subjects: 46
Study: 34172261

Group type: EXPERIMENTAL
Intervention: High-volume suction with an aerosol cannula (Group B)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Medium-volume suction (Group A)
Number of subjects: 24
Study: 33632282

Group type: EXPERIMENTAL
Intervention: Checklist-based educational program (once)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Checklist-based educational program (twice)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 84
Study: 34983144

Group type: EXPERIMENTAL
Intervention: Methylprednisolone plus azithromycin (Group B)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Azithromycin alone (Group A)
Number of subjects: 102
Study: 32279619

Group type: EXPERIMENTAL
Intervention: Endovascular treatment for acute ischemic stroke
Number of subjects: 1988

Group type: EXPERIMENTAL
Intervention: Collateral status on baseline computed tomography angiography
Number of subjects: 1988

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 1988

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 1988

Group type: EXPERIMENTAL
Intervention: Blood glucose level
Number of subjects: 1988

Group type: EXPERIMENTAL
Intervention: Occlusion of the intracranial segment of the internal carotid artery with occlusion of the terminus
Number of subjects: 1988
Study: 34916068

Group type: EXPERIMENTAL
Intervention: Sertraline (n = 106) for 8 weeks
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo (n = 116) for 8 weeks
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Bupropion (n = 37) for 8 weeks after sertraline nonresponse
Number of subjects: 222
Study: 32664244

Group type: EXPERIMENTAL
Intervention: PATCH self-assessment
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard care nurse-led assessment
Number of subjects: 52
Study: 35579104

Group type: EXPERIMENTAL
Intervention: Oral care tablet containing kiwifruit powder (intervention II)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Tongue brushing (intervention I)
Number of subjects: 32
Study: 37562904

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg tablet
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 34409964

Group type: EXPERIMENTAL
Intervention: Community-based, 6-month controlled lifestyle intervention focusing on plant-based diet, physical activity, stress management, and improved social life
Number of subjects: 201

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 201
Study: 32925629

Group type: EXPERIMENTAL
Intervention: Induction of labor at 39 weeks
Number of subjects: 7112

Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 7112

Group type: COMPARATOR
Intervention: Not participating in research
Number of subjects: 7112

Group type: COMPARATOR
Intervention: Declining consent due to family or friends' objection
Number of subjects: 7112
Study: 36175917

Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (LDN) administered for 12 weeks, followed by an additional 12 weeks for all participants.
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo administered for 12 weeks, followed by LDN for all participants.
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-dose naltrexone (LDN)
Number of subjects: 48
Study: 33175114

Group type: EXPERIMENTAL
Intervention: Cognitive prehabilitation (tablet-based cognitive exercise targeting memory, speed, attention, flexibility, and problem-solving functions)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Control group (no cognitive prehabilitation)
Number of subjects: 251
Study: 33383935

Group type: EXPERIMENTAL
Intervention: Randomized (1-1/e)-optimal algorithm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deterministic (1-1/e)-approximation algorithm
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deterministic approximation algorithm with nearly ▵-1 approximation ratio
Number of subjects: 0
Study: 36155955

Group type: EXPERIMENTAL
Intervention: Clozex
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Zip
Number of subjects: 32

Group type: COMPARATOR
Intervention: Suture
Number of subjects: 32
Study: 34243086

Group type: EXPERIMENTAL
Intervention: Powered air-purifying respirator (PAPR) with PM filter
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Powered air-purifying respirator (PAPR) with PM and VOCs filter
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Powered air-purifying respirator (PAPR) with sham filter
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: N95 mask
Number of subjects: 39

Group type: COMPARATOR
Intervention: Sham mode (control)
Number of subjects: 39
Study: 33592280

Group type: EXPERIMENTAL
Intervention: Magnetic enteric-coated tablet containing diclofenac sodium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (before domperidone administration)
Number of subjects: 0
Study: 33930858

Group type: EXPERIMENTAL
Intervention: Hybrid Simulation (HS)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Low Fidelity Simulation (LFS)
Number of subjects: 62
Study: 34253560

Group type: EXPERIMENTAL
Intervention: Fried meat consumption (4 times per week for 4 weeks)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (restricted from fried meat intake for 4 weeks)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Fried meat consumption
Number of subjects: 117
Study: 33115524

Group type: EXPERIMENTAL
Intervention: Technology-enhanced intervention using video visits for caregiver support and education during transitions.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care practices (control group).
Number of subjects: 0
Study: 35332771

Group type: EXPERIMENTAL
Intervention: Noble metal-alloy ETT (coated Bactiguard Infection Protection ETTs)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard non-coated ETT
Number of subjects: 180
Study: 34375127

Group type: EXPERIMENTAL
Intervention: Single-use digital flexible ureteroscope (ZebraScope™)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Reusable flexible ureteroscope (URF-V)
Number of subjects: 49
Study: 35685210

Group type: EXPERIMENTAL
Intervention: Frozen-thawed embryo transfer (FET)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Multivariate logistic regression (MLR) model
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: Statistical nomogram
Number of subjects: 424
Study: 33742064

Group type: EXPERIMENTAL
Intervention: Interval cycling followed by upper body resistance exercise (ER‐Arm)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Upper body resistance exercise only (R‐Arm)
Number of subjects: 8
Study: 32264985

Group type: EXPERIMENTAL
Intervention: iMAPS therapy (six sessions of therapy using imagery techniques and imagery rescripting techniques)
Number of subjects: 5